WO2009121788A1 - New process for the preparatiion of cyclohexanecarboxylic acid dericatives - Google Patents
New process for the preparatiion of cyclohexanecarboxylic acid dericatives Download PDFInfo
- Publication number
- WO2009121788A1 WO2009121788A1 PCT/EP2009/053581 EP2009053581W WO2009121788A1 WO 2009121788 A1 WO2009121788 A1 WO 2009121788A1 EP 2009053581 W EP2009053581 W EP 2009053581W WO 2009121788 A1 WO2009121788 A1 WO 2009121788A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- alkyl
- compound
- alkylene
- process according
- Prior art date
Links
- 0 *CC1(CCCCC1)C(*)=O Chemical compound *CC1(CCCCC1)C(*)=O 0.000 description 2
- GDLOOQFSFHLRKT-UHFFFAOYSA-N CC1(CCCCC1)C(N)=O Chemical compound CC1(CCCCC1)C(N)=O GDLOOQFSFHLRKT-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/58—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/06—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Definitions
- the present invention relates to a process for the preparation of a cyclohexanecarboxylic acid derivative which is useful as an intermediate in the preparation of pharmaceutically active compounds.
- the present invention provides a process for the preparation of compound of formula I a :
- R a is :
- R h is :
- R a and R together with the carbon atom to which they are attached form a three, four, five or six membered cycloalkyl ring that optionally includes an additional heteroatom selected from O, N and S.
- R ca and R cb are independently: - hydrogen
- Y is cyano
- R' is hydrogen or (Ci-C 8 )alkyl
- the present invention provides a process for the preparation of the compound of a cyclohexanecarbonitrile derivative of formula (I):
- R 1 is (Ci-Cs)alkyl, preferably pent-3-yl,
- an alkylating agent such as a 1-1IaIo-CH 2 R 1 , preferably l-halo-2-ethylbutane, or a sulfonate ester OfR 1 CH 2 -OH, preferably of 2-ethyl-l-butanol, wherein R 1 Is as defined above, and a Grignard reagent, such as (Ci-C6)alkyl-magnesium-halide, phenyl-magnesium-halide, heteroaryl-magnesium-halide or (C3-C6)cycloakyl-magnesium-halide.
- an alkylating agent such as a 1-1IaIo-CH 2 R 1 , preferably l-halo-2-ethylbutane, or a sulfonate ester OfR 1 CH 2 -OH, preferably of 2-ethyl-l-butanol, wherein R 1 Is as defined above
- a Grignard reagent
- the above mentioned coupling reaction is carried out in the presence of a secondary amine.
- the Grignard reagent is added to the cyclohexanecarbonitrile, more preferably in the presence of a secondary amine, followed by the addition of an alkylating agent, as defined above.
- the above mentioned coupling reaction is followed by a mineral acid quenching, such as hydrofluoric acid, hydrochloric acid, boric acid, acetic acid, formic acid, nitric acid, phosphoric acid or sulfuric acid, most preferably by hydrochloric acid.
- a mineral acid quenching such as hydrofluoric acid, hydrochloric acid, boric acid, acetic acid, formic acid, nitric acid, phosphoric acid or sulfuric acid, most preferably by hydrochloric acid.
- the present invention further provides a process for the preparation of a cyclohexanecarboxylic acid derivative of formula (III):
- R 1 is as defined previously, comprising:
- the compound of formula (III) may be used as intermediate in the synthesis of valuable pharmaceutical compounds.
- l-(2-ethyl-butyl)-cyclohexanecarboxylic acid may be used in the synthesis of the ones as described in EP 1,020, 439.
- halo means fluoro, chloro, bromo or iodo, preferably chloro or bromo.
- alkali metal or “alkali” refers to lithium, sodium, potassium, rubidium and caesium. Preferable alkali metal is lithium or sodium. Of these, sodium is most preferred.
- (Ci-Cs)alkyl refers to a branched or straight hydrocarbon chain of one to eight carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t-butyl, pentyl, hexyl and heptyl. (Ci-Ce)alkyl is preferred.
- (Ci-C 6 )alkylcarbonyl means a group -C(O)-R aa wherein R aa is (Ci-C 6 )alkyl as defined herein.
- (Ci-C 6 )alkoxy means a moiety of the formula -OR a , wherein R a is an (Ci-C 6 )alkyl moiety as defined herein.
- alkoxy moieties include, but are not limited to, methoxy, ethoxy, isopropoxy, and the like.
- (Ci-C 6 )Alkoxy(Ci-C 6 )alkylene means a moiety of the formula R ac -O-R ad - where R ac is (Ci- C 6 )alkyl and R ad is (Ci-C 6 )alkylene as defined herein.
- Exemplary (Ci-C 6 )alkoxy(Ci-C 6 )alkyl groups include, by way of example, 2-methoxyethyl, 3-methoxypropyl, l-methyl-2- methoxyethyl, l-(2-methoxyethyl)-3-methoxypropyl, and l-(2-methoxyethyl)-3-methoxypropyl.
- (Ci-C6)alkylene means a linear saturated divalent hydrocarbon moiety of one to six carbon atoms or a branched saturated divalent hydrocarbon moiety of three to six carbon atoms, e.g., methylene, ethylene, 2,2-dimethylethylene, propylene, 2-methylpropylene, butylene, pentylene, and the like.
- halo-(Ci-C8)alkyl refers to an alkyl, as defined above, substituted with one or more halogen atoms, preferably with one to three halogen atoms. More preferred halo-(Ci-C8)alkyl is the chloro- and fluoro-(Ci-C 8 )alkyl.
- halo-(Ci-C6)alkoxy refers to an alkoxy, as defined above, substituted with one or more halogen atoms, preferably with one to three halogen atoms. More preferred halo-(Ci-Ce)alkoxy are the chloro- and fluoro-(Ci-Cs)alkoxy.
- (C3-C6)cycloalkyl refers to a single saturated carbocyclic ring of thee to six ring carbons, such as cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. Cycloalkyl may optionally be substituted with one or more substituents, preferably one, two or three, substituents.
- cycloalkyl substituent is selected from the group consisting of (Ci-C 6 )alkyl, hydroxy, (C 1 - Ce)alkoxy, halo(Ci-C6)alkyl, halo(Ci-C6)alkoxy, halo, amino, mono- and di(Ci-C6)alkylamino, hetero(Ci-C 6 )alkyl, acyl, aryl and heteroaryl.
- (C 3 -C 6 )Cycloalkyl(Ci-C 6 )alkylene refers to a moiety of the formula R ae -R af - where R ae is (C 3 - C6)cycloalkyl and R a is (Ci-C6)alkylene as defined herein.
- “Secondary amine” refers to an amine of formula HNR 2 R 3 wherein R 2 and R 3 may be the same or different and are independently selected from (Ci-C 6 )alkyl or (C 3 -C 6 )cycloalkyl, or R 2 and R 3 taken together with the nitrogen atom to which they are attached, form a (C 4 -Cs) heterocycloalkane optionally containing an additional heteroatom selected from O or N.
- Representative examples include, but are not limited to, piperidine, 4-methyl-piperidine, piperazine, pyrrolidine, morpholine, dimethylamine, diethylamine, diisopropylamine, dicyclohexylamine, ethylmethylamine, ethylpropylamine and methylpropylamine.
- the secondary amine is chosen from diethylamine, diisopropylamine, dicyclohexylamine, ethylmethylamine, ethylpropylamine, methylpropylamine and morpholine.
- the more preferred secondary amine is diethylamine or diisopropylamine, most preferred diethylamine.
- -C8)heterocycloalkane refers to a saturated non-aromatic cyclic compound of 4 to 8 ring atoms in which one or two ring atoms are heteroatoms selected from N or O, and the heterocycloalkane may be optionally substituted with one or more (Ci-C3)alkyl, preferably one (Ci-C 3 )alkyl.
- Acyl means a group of the formula -C(O)-R ag , -C(O)-OR ag ' , -C(O)-OC(O)R ag or -C(O)- NR a gR ah wherein R a g ⁇ hydrogen, (C 1 -C 6 )alkyl, halo(C 1 -C 6 )alkyl, heteroalkyl or amino as defined herein, and R ah is hydrogen or (Ci-Ce)alkyl as defined herein.
- Amino means a group -NR a R wherein R a and R each independently is hydrogen or (C 1 - C 6 )alkyl.
- Aryl means a monovalent monocyclic or bicyclic aromatic hydrocarbon moiety which is optionally substituted with one or more, preferably one, two or three, substituents, each of which is preferably selected from the group consisting of hydroxy, (Ci-C6)alkoxy, halo(Ci-C6)alkyl, halo(Ci-C6)alkoxy, halo, nitro, cyano, amino, mono- and di(Ci-C6)alkylamino, methylenedioxy, ethylenedioxy, acyl, hetero(Ci-C6)alkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted aralkyl, and optionally substituted heteroaralkyl.
- aryl includes, but is not limited to, phenyl, 1-naphthyl, 2-naphthyl, and the like, each of which can be substituted or unsubstituted.
- Alkyl refers to a moiety of the formula -R bc -R bd where R bd is aryl and R bc is (Ci-C 6 )alkylene as defined herein.
- Arylcarbonyl means a group -C(O)-R e wherein R e is aryl as defined herein.
- Aryl-(Ci-C 6 )alkylene-carbonyl means a group -C(O)-R bf -R bg wherein R bf is (d-C 6 )alkylene and R bf is aryl as defined herein.
- Heteroaryl means a monovalent monocyclic or bicyclic moiety of 5 to 12 ring atoms having at least one aromatic ring containing one, two, or three ring heteroatoms selected from N, O, or S (preferably N or O), the remaining ring atoms being C, with the understanding that the attachment point of the heteroaryl moiety will be on an aromatic ring.
- the heteroaryl ring is optionally substituted independently with one or more substituents, preferably one, two or three substituents, each of which is independently selected from (Ci-C6)alkyl, halo(Ci-C6)alkyl, hydroxy, (Ci-Ce)alkoxy, halo, nitro and cyano.
- heteroaryl includes, but is not limited to, pyridyl, furanyl, thienyl, thiazolyl, isothiazolyl, triazolyl, imidazolyl, isoxazolyl, pyrrolyl, pyrazolyl, pyrimidinyl, benzofuranyl, tetrahydrobenzo furanyl, isobenzo furanyl, benzothiazolyl, benzoisothiazolyl, benzo triazolyl, indolyl, isoindolyl, benzoxazolyl, quinolyl, tetrahydroquinolinyl, isoquinolyl, benzimidazolyl, benzisoxazolyl or benzothienyl, imidazo[l,2-a]-pyridinyl, imidazo[2,l-b]thiazolyl, and the derivatives thereof.
- Heteroaryl(Ci-C6)alkylene and “heteroaralkyl” refers to a moiety of the formula Ar z -R y -, where Ar z is heteroaryl and R y is (Ci-C6)alkylene as defined herein.
- Heteroarylcarbonyl means a group -C(O)-R wherein R is heteroaryl as defined herein.
- Heteroaryl-(Ci-C 6 )alkylene-carbonyl means a group -C(O)-R bf -R bg wherein R bf is (C 1 - C6)alkylene and R bf is heteroaryl as defined herein.
- Heterocyclyl means a saturated or unsaturated non-aromatic cyclic moiety of 3 to 8 ring atoms in which one or two ring atoms are heteroatoms selected from N, O, or S(O) n (where n is an integer from O to T), preferably N or O, the remaining ring atoms being C, where one or two C atoms may optionally be replaced by a carbonyl group.
- the heterocyclyl ring may be optionally substituted independently with one or more, preferably one, two, or three, substituents, each of which is independently selected from (Ci-C6)alkyl, halo(Ci-C6)alkyl, hydroxy(Ci-C6)alkyl, halo, nitro, cyano, cyano(Ci-C6)alkyl, hydroxy, (Ci-C6)alkoxy, amino, mono- and di(Ci- C 6 )alkylamino, aralkyl, -(X) n -C(O)R 6 (where X is O or NR f , n is O or 1, R e is hydrogen, (C 1 - C ⁇ )alkyl, halo(Ci-Ce)alkyl, hydroxy (when n is O), (Ci-C6)alkoxy, amino, mono- and di(Ci- C6)alkylamino, or optionally substituted phenyl, and R f
- a particularly preferred group of heterocyclyl substituents include (Ci-C6)alkyl, halo(Ci- C ⁇ )alkyl, hydroxy(Ci-C ⁇ 5)alkyl, halo, hydroxy, (Ci-C ⁇ 5)alkoxy, amino, mono- and di(Ci- C6)alkylamino, aralkyl, and -S(O) n R k .
- heterocyclyl includes, but is not limited to, tetrahydrofuranyl, tetrahydropyranyl, piperidino, N-methylpiperidin-3-yl, piperazino, N-methylpyrrolidin-3-yl, 3-pyrrolidino, morpholino, thiomorpholino, thiomorpholino-1 -oxide, thiomorpho lino- 1,1 -dioxide, 4-(l,l-dioxo-tetrahydro-2H-thiopyranyl), pyrrolinyl, imidazolinyl, N-methanesulfonyl-piperidin-4-yl, and the derivatives thereof, each of which may be optionally substituted.
- ⁇ etero(Ci-C 8 )alkyl means an alkyl moiety as defined herein wherein one or more, preferably one, two or three, hydrogen atoms have been replaced with a substituent independently selected from the group consisting of -OR a , -NR R c and -S(O) n R (where n is an integer from 0 to 2), with the understanding that the point of attachment of the heteroalkyl moiety is through a carbon atom, wherein R a is hydrogen, acyl, (Ci-Ce)alkoxycarbonyl, (Ci-C 6 )alkyl, hydroxy(Ci-C 6 )alkyl, (Ci-C6)alkoxy(Ci-C6)alkyl, (Ci-C6)alkylsulfonyl, aminocarbonyl, aminosulfonylamino, (C 3 - C 6 )cycloalkyl, or (C 3 -C 6 )cycloalkyl(
- Representative examples include, but are not limited to, 2-hydroxyethyl, 3- hydroxypropyl, 2-hydroxy-l-hydroxymethylethyl, 2,3-dihydroxypropyl, 1 -hydro xymethylethyl, 3-hydroxybutyl, 2,3-dihydroxybutyl, 2-hydroxy- 1 -methylpropyl, 2-aminoethyl, 3-aminopropyl, 2-methylsulfonylethyl, amino sulfonylmethyl, amino sulfonylethyl, aminosulfonylpropyl, methylaminosulfonylmethyl, methylamino sulfonylethyl, methylaminosulfonylpropyl, and the like.
- Alkylsulfonyl means a moiety of the formula -SO 2 R bl wherein R bl is (Ci-C 6 )alkyL
- nitrosylating agenf' comprises nitrosylsulfuric acid, sodium nitrite or a mixture thereof. Most preferably, the nirtosylating agent is nitrosylsulfuric acid.
- sulfonate ester OfR 1 CH 2 -OH or (R ca )(R cb )CH-OH refers to a substituted or an unsubstituted phenyl- sulfonate, an unsubstituted naphthalene-sulfonate or a ester derivative OfR 1 CH 2 -OH or (R ca )(R cb )CH-0H, respectively, wherein substituted phenyl and the (Ci-C ⁇ )alkyl chain, R 1 , R ca , R cb are as defined herein.
- Representative examples include, but are not limited to, benzenesulfonic acid 2-ethyl-butyl ester, 1-naphthalenesulfonic acid 2-ethyl-butyl ester, 2-naphthalenesulfonic acid 2-ethyl-butyl ester, toluene-4-sulfonic acid 2-ethyl-butyl ester, 4-nitro-benzenesulfonic acid 2-ethyl-butyl ester, 2,4,6-trimethyl-benzenesulfonic acid 2-ethyl- butyl ester, ethanesulfonic acid 2-ethyl-butyl ester, methanesulfonic acid 2-ethyl-butyl ester and butanesulfonic acid 2-ethyl-butyl ester.
- strong acid refers to an acid that dissociates completely in an aqueous solution with a pH ⁇ 2.
- the strong acids include, but are not limited to: sulphuric acid (H 2 SO 4 ), hydrohalo genie acid (i.e. HX" wherein X" is I, Br, Cl or F), nitric acid (HNO 3 ), phosphoric acid (H 3 PO 4 ) and combinations thereof.
- the strong acid is H 2 S ⁇ 4 or hydrohalogenic acid, wherein X" is Br or Cl.
- the strong acid is H 2 SO 4 .
- concentration OfH 2 SO 4 in water is in the range of 75% to 90 %, more preferably 78 to 83 %, most preferably 82.5 %.
- aqueous base refers to a solution comprising a base and water. Numerous bases which readily dissolve in water are known in the art, such as NaOH, KOH, Ca(OH) 2 , Mg(0H) 2 , preferably
- the aqueous base has a pH of 12 to 14.
- the present invention provides a process comprising the synthetic steps represented in the following scheme 1 :
- the process comprises reacting a cyclohexanecarboxylic acid derivative of formula (III) with a halogenating agent, such as PX3, PX5, SOX 2 or NCX, to obtain the acyl halide of formula (V).
- a halogenating agent such as PX3, PX5, SOX 2 or NCX
- the halogenating step is preferably carried out in the presence of tri-(Ci-C5)alkylamine.
- the process comprises reacting acyl halide with bis(2-aminophenyl)disulf ⁇ de to acylate the amino groups of the bis(2-aminophenyl)disulfide, reducing the amino-acylated disulfide product with a reducing agent such as triphenylphosphine, zinc or sodium borohydride to yield the thiol product, and acylating the thiol group in the thiol product with R 4 C(O)X', wherein X' is I, Br, Cl or F.
- a reducing agent such as triphenylphosphine, zinc or sodium borohydride
- the additional steps may be performed, e.g., according to the procedures described in Shinkai et al, J. Med. Chem. 43:3566-3572 (2000) or WO 2007/051714.
- the halogenating agent is chosen from thionyl chloride, phosphorus pentachloride, oxalyl chloride, phosphorus tribromide and cyanuric fluoride, most preferably thionyl chloride.
- the acylating agent is R 4 C(O)X', wherein X' is Cl. Most preferably R 4 is isopropyl.
- the present invention provides a process for the preparation of a cyclohexanecarboxylic acid derivative of formula (III)!
- R 1 is as defined above, comprising: a) hydrolysing a cyclohexanecarbonitrile derivative of formula (I):
- a mineral acid such as hydrofluoric acid, hydrochloric acid, boric acid, nitric acid,
- the biphasic mixture is separated, the water solution is back extracted with an organic solvent, and H 2 O is added to the combined organic phases of the reaction mixture.
- the pH of the biphasic solution is adjusted to 10 to 14, preferably to a pH of 11 to 13.5 by addition of a basic aqueous solution as defined herein, preferably over a period of 10 min.
- the organic phase is discarded and a water saturated solution of NaCl and an organic solvent, as defined herein, more preferably toluene, is added to the water phase, more preferably the organic phase is discarded and water and an organic solvent is added to the water phase.
- the pH of the mixture is adjusted to a pH of 6 to 7 by addition of a mineral acid as previously defined.
- the water phase is discarded and the organic layer is concentrated.
- organic solvent referred herein comprises ether like solvent (e.g. tetrahydrofuran, methyltetrahydrofuran, diisopropyl ether, t-butylmethyl ether or dibutyl ether, ethyl acetate, butyl acetate), alcohol solvent (e.g. methanol or ethanol), aliphatic hydrocarbon solvent (e.g. hexane, heptane or pentane), saturated alicyclic hydrocarbon solvent (e.g. cyclohexane or cyclopentane) or aromatic solvent (e.g. toluene or t-butyl-benzene)
- ether like solvent e.g. tetrahydrofuran, methyltetrahydrofuran, diisopropyl ether, t-butylmethyl ether or dibutyl ether, ethyl acetate, butyl acetate
- alcohol solvent e.g.
- the present invention provides processes as described above wherein nitrosylating agent is generated in situ e.g. mixing H 2 SO 4 and nitrous acid (HNO 2 ) or H2SO 3 /HNO 3 or N2O3/H2SO4 or HNO3/SO2 to obtain nitrosulfuric acic (NOHSO 4 ).
- nitrosylating agent is generated in situ e.g. mixing H 2 SO 4 and nitrous acid (HNO 2 ) or H2SO 3 /HNO 3 or N2O3/H2SO4 or HNO3/SO2 to obtain nitrosulfuric acic (NOHSO 4 ).
- the present invention provides a process for the preparation of the compound of formula (III), comprising the preparation of a cyclohexanecarbonitrile derivative of formula (I) followed by the hydrolysis steps as described above and in the following scheme 2, wherein R 1 is as defined above.
- the halide of Grignard reagent is chosen from chloride, bromide and iodide, more preferably chloride or bromide, most preferably chloride.
- the preferred alkyl of the Grignard reagent is (C 1 -C3) alkyl, more preferably methyl.
- the most preferred Grignard reagent is methylmagnesiumchloride.
- the preferred alkylating agent is l-halo-2-ethylbutane, most preferably l-bromo-2-ethylbutane.
- the alkylation is performed with catalytic amount of secondary amine, such as 0.01 to 0.5 equivalent of secondary amine with respect to cyclohexylcarbonitrile, most preferably 0.20 eq.
- the dosing time of the methylmagnesiumchloride is preferably 0.5 to 4h, most preferably 1.5h. This addition is preferably carried out at room temperature.
- the 2- ethylbutylbromide dosing time is preferably 0.5 to 2h, most preferably Ih.
- the 2- ethylbutylbromide is preferably added at temperature of 40 to 5OC.
- a nonprotic organic solvent is the preferred solvent during the alkylation, such as tetrahydrofuran, alone or in combination with another nonprotic solvent, e.g. from the group of the apolar solvents hexane, heptane, methyl tetrahydrofiirane, toluene and t-butyl-benzene, more preferably hexane, heptane, toluene and t-butyl-benzene. Most preferably the nonprotic solvent is tetrahydrofuran.
- the hydro lysing agent of the cyclohexanecarbonitrile derivative of formula (I) is a strong acid.
- the most preferred strong acid for step a) is H 2 SO 4 .
- the hydrolysis step is either carried out by dosing compound of formula (I) to H 2 SO 4 at temperature of 80 0 C to 120 0 C or both compound of formula (I) and H 2 SO 4 are heated as a mixture to a temperature of 80 0 C to 120 0 C. More preferably the temperature in both modes of addition is 95 to 110 0 C, most preferably 105 to 110 0 C. 1.5 to 4 equivalents of H 2 SO 4 with respect to compound of formula (I) is preferably used. More preferably 1.9 to 3.6 equivalents are used.
- the hydrolysis is carried out with excess H2O, preferably 5 to 25 eq. of H 2 O with respect to the compound of formula (I), more preferably 10 to 20 eq. Most preferably, 14 to 16 eq. OfH 2 O is used with respect to the compound of formula (I).
- nitrosylsulfuric acid For the hydrolysis of the amide of formula (IV), preferably 1.1 to 1.4 equivalents of nitrosylsulfuric acid is used, most preferably 1.2 to 1.4 equivalent. Either nitrosylsulfuric acid is added first and followed by H 2 O or the H 2 O is first added and followed by addition of nitrosylsulfuric acid. The second addition mode is preferred.
- the dosing temperature is at 20 to 65 0 C, most preferably 60 to 65 0 C.
- the "basic aqueous solution" for the extraction step (c) is preferably chosen from inorganic bases or organic bases, a mixture thereof, or from commonly known buffering solutions of suitable pH.
- the preferred inorganic base is an alkali base, such as alkali carbonate, alkali bicarbonate, alkali borate, alkali phosphate, alkali-hydroxide.
- a more preferred basic aqueous solution is chosen from solution of potassium bicarbonate, sodium bicarbonate, potassium carbonate, sodium carbonate, sodium borate, sodium hydroxide, or a mixture thereof.
- the most preferred basic aqueous solution is a solution of sodium bicarbonate, sodium hydroxide or a mixture thereof.
- the present invention provides a process for the preparation of [2-([[l- (2-ethylbutyl)-cyclohexyl]-carbonyl]amino)phenyl]2-methylpropanethioate comprising the formation of a compound of formula (I) obtained by any of the processes and conditions mentioned previously.
- the starting materials and reagents which do not have their synthetic route explicitly disclosed herein, are generally available from commercial sources or are readily prepared using methods well known to the person skilled in the art.
- compound of formula (II) is commercially available or can be prepared by procedures known to the skilled person.
- a compound of formula (IV), wherein R 1 is pent-3-yl, is new. Accordingly, a further embodiment the present invention provides a compound of formula (IV)
- the methods of the present invention may be carried out as semi-continuous or continuous processes, more preferably as continuous processes.
- a solution (S 1 ) of Grignard reagent (most preferably methylmagnesiumchloride) and secondary amine (most preferably diethylamine), and a solution (S 2 ) of a cyclohexanecarbonitrile are continuously added into a reaction vessel while preferably being mixed.
- a solution (S 3 ) of an alkylating agent most preferably 2-ethylbutylbromide
- the reaction mixture is then treated with HCl, the collected organic phase are washed with water , and concentrated under reduced pressure to yield cyclohexanecarbonitrile derivative of formula (I).
- the preferred reaction vessels are microreactors consisting of mixing and reaction chambers.
- the speeds of addition of solution (S 1 ) and solution (S 2 ) are between 2.2 and 3.1 mmol/min (most preferably 2.64 mmol/min) and between 1.9 and 2.8 mmol/min (more preferably 2.33 mmol/min), respectively.
- the contacting time of solution (S 1 ) and (S 2 ) is less than 60 sec ( more preferably less than 30 sec,most preferably 12 sec).
- the speeds of addition of solution S 3 is between 2.1 and 3.0mol/min, more preferably 2.58 mmol/min and preferably the contacting time is less than 20 min, more preferably is 6 min.
- reaction mixture was stirred for a further 2 h at 105 0 C-110 0 C, by GC analysis less than 0.5% of starting nitrile remained in the mixture.
- reaction mixture was cooled down to 65°C, 100 ml of heptane was added. Then, 26.5g (1.47 mol) OfH 2 O was added over a period 5 to 10 min.
- reaction mixture at 60-65 0 C, under heavy stirring (800rpm), over a period of 60 min, was added 44.5 g (140 mmol) of nitrosylsulfuric acid (40% in sulfuric acid), with the help of an infusion pump. The reaction mixture was stirred for a further 30 min at 60-65 0 C.
- the reaction mixture was allowed to cool and settle down to room temperature.
- the aqueous phase was discarded.
- Then to the organic phase was added 100.0 ml H 2 O.
- the pH of the solution was adjusted to 12.5-13 by addition of approximately 38g of sodium hydroxide (28% solution in water) at 20-30 0 C while stirring, over a 10 min period with the help of dropping funnel. Both phases were allowed to separate for 5 min.
- the organic phase was discarded and 24g (20ml) saturated solution of NaCl and 240 ml of toluene were added to the water phase. Over a 10 min period, with the help of dropping funnel, while stirring the pH was adjusted to 6-7 with approximately 26g HCl ( 37% solution in water). Both phases were allowed to separate for 5 min.
- a solution of 8.74g (80mmol) cyclohexylcarbonitrile and 40.0 ml THF were dosed within 105 minutes with a solution of methylmagnesiumchloride (3M, 30mls, 89 mmol) in THF at 20-26 0 C. After dosing was completed, the solution was heated to 46 0 C and dosed within 60 minutes with 15.6g (94.5mmol) 2-ethylbutylbromide at a rate that the internal temperature was kept between 45-50 0 C.
- reaction mixture was cooled down to 20-25 0 C and treated with 28 ml Heptane, cooled to O 0 C and treated with 45 ml HCl (IN) within 60 minutes keeping the internal temperature between 3-6 0 C. The temperature was adjusted to 20-26 0 C and the mixture was stirred for 30 minutes. After that time the phases were separated.
- the pH of the solution was adjusted to 12.5-13 by addition of approximately 17g of sodium hydroxide (28% solution in water) at 20-30 0 C while stirring, over a 10 min period with the help of dropping funnel. Both phases were allowed to separate for 5 min. The organic phase was discarded and 100 ml of toluene were added to the water phase. Over a 10 min period, with the help of dropping funnel, while stirring the pH was adjusted to 6-7 with approximately 12 g HCl ( 37% solution in water). Both phases were allowed to separate for 5 min.
- EHRFELD's microreactor units were used in the following example. To avoid engassing within the reaction equipment a preparative step was necessary before entering the micro -reaction system. A solution A of 96.05 g methylmagnesiumchloride (3M, 296.8 mmol) in THF was dosed within 30 minutes with a solution of 23.06 g (309.72 mmol) diethylamine in 116.5 ml THF at 20-25 0 C. After additional stirring at 20-25 0 C, the reaction mixture was treated with an argon flow for 30 minutes to strip methane.
- 3M methylmagnesiumchloride
- diethylamine diethylamine
- the solution (A) was continuous dosed with a solution (B) of 28.34 g (258.1 mmol) Cyclohexancarbonitrile in 123.2 ml THF at 20-25 0 C in a mixing system, where the reaction takes place. [Solution (A) 2.25 ml/min, solution (B) 1.38 ml/min, residence time 12 seconds].
- the mixture from this deprotonation was continuously dosed together with a solution (C) of 47.14 g (283.9 mmol) 2-Ethyl-butyl-bromide in 112 ml THF at 66 0 C after a mixing device into a micro reactor. [Solution (C) 1.38 ml/min, residence time 6 minutes].
- reaction mixture (Sample 15 min flow) was cooled down to 20-25 0 C and treated with 20.0 ml HCl (IN) within 30 minutes keeping the internal temperature between 25-30 0 C. The mixture was stirred for 30 minutes. After that time the phases were separated. The collected organic phase was washed with 27 ml water, concentrated under reduced pressure (190 mbar) at 50 0 C and dried in vacuo (15 mbar) at 80 0 C yielding 5.17 g of l-(2-ethyl-butyl)-cyclohexylcarbonitrile with an HPLC assay of 83.5% (yield 63.7%).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
Claims
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0909813-5A BRPI0909813B1 (en) | 2008-04-04 | 2009-03-26 | "PROCESSES FOR PREPARATION OF CYCLE-HEXANOCARBOXYLIC ACID DERIVATIVES, AND INTERMEDIATE" |
CA2717955A CA2717955C (en) | 2008-04-04 | 2009-03-26 | New process for the preparation of cyclohexanecarboxylic acid derivatives |
JP2011502347A JP5564487B2 (en) | 2008-04-04 | 2009-03-26 | Novel process for producing cyclohexanecarboxylic acid derivatives |
EP09728035.8A EP2274278B1 (en) | 2008-04-04 | 2009-03-26 | New process for the preparatiion of cyclohexanecarboxylic acid dericatives |
CN200980111292.3A CN101981001B (en) | 2008-04-04 | 2009-03-26 | Prepare the new method of naphthenic acid derivant |
ES09728035.8T ES2592727T3 (en) | 2008-04-04 | 2009-03-26 | New process for the preparation of cyclohexanecarboxylic acid derivatives |
AU2009231423A AU2009231423B2 (en) | 2008-04-04 | 2009-03-26 | New process for the preparation of cyclohexanecarboxylic acid derivatives |
KR1020107021983A KR101279751B1 (en) | 2008-04-04 | 2009-03-26 | New process for the preparation of cyclohexanecarboxylic acid derivatives |
MX2010009926A MX2010009926A (en) | 2008-04-04 | 2009-03-26 | New process for the preparatiion of cyclohexanecarboxylic acid dericatives. |
IL207431A IL207431A (en) | 2008-04-04 | 2010-08-05 | Process for the preparation of a cyclohexanecarboxylic acid derivative and intermediate thereof |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08154078 | 2008-04-04 | ||
EP08154078.3 | 2008-04-04 | ||
EP09151065 | 2009-01-22 | ||
EP09151065.1 | 2009-01-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009121788A1 true WO2009121788A1 (en) | 2009-10-08 |
Family
ID=40749840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2009/053581 WO2009121788A1 (en) | 2008-04-04 | 2009-03-26 | New process for the preparatiion of cyclohexanecarboxylic acid dericatives |
Country Status (12)
Country | Link |
---|---|
US (1) | US8143442B2 (en) |
EP (1) | EP2274278B1 (en) |
JP (1) | JP5564487B2 (en) |
KR (1) | KR101279751B1 (en) |
CN (1) | CN101981001B (en) |
AU (1) | AU2009231423B2 (en) |
BR (1) | BRPI0909813B1 (en) |
CA (1) | CA2717955C (en) |
ES (1) | ES2592727T3 (en) |
IL (1) | IL207431A (en) |
MX (1) | MX2010009926A (en) |
WO (1) | WO2009121788A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012035017A1 (en) | 2010-09-16 | 2012-03-22 | F. Hoffmann-La Roche Ag | New process |
WO2013007712A1 (en) | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Method for the preparation of cyclohexanecarboxylic acid |
JP2014510019A (en) * | 2010-12-16 | 2014-04-24 | エフ.ホフマン−ラ ロシュ アーゲー | Process for the preparation of aromatic thiol derivatives by hydrogenation of disulfides. |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2978859T3 (en) | 2013-03-27 | 2018-09-03 | Hoffmann La Roche | Genetic markers for predicting responsiveness to therapy |
CN105277462A (en) * | 2014-06-19 | 2016-01-27 | 浙江海洋学院 | Composition content analysis method of tank bottom aged oil sludge |
EP3174995B1 (en) | 2014-07-30 | 2020-08-19 | F.Hoffmann-La Roche Ag | Genetic markers for predicting responsiveness to therapy with hdl-raising or hdl mimicking agent |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4283420A (en) * | 1978-04-27 | 1981-08-11 | Labaz | Pharmaceutically active cyclohexyl compounds and their preparation |
EP0094633A2 (en) * | 1982-05-17 | 1983-11-23 | Hoechst Aktiengesellschaft | Spiro-2-aza-alkane-3-carbonitriles, process for their preparation and their use |
EP1020439A1 (en) * | 1997-02-12 | 2000-07-19 | Japan Tobacco Inc. | Cetp activity inhibitors |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2899458A (en) * | 1959-08-11 | Process for producing oxy aromatic | ||
US4129595A (en) * | 1978-03-29 | 1978-12-12 | Chevron Research Company | Preparation of chloroacetyl chloride |
IT1292037B1 (en) | 1997-05-30 | 1999-01-25 | Bracco Spa | PROCESS FOR THE PREPARATION OF 5- (ACETYL 62,3-DIIDROXYPROPYL) - AMINO) -N, N'-BIS (2,3-DIIDROXYPROPYL) -2,4,6-TRIIODE-1,3-BENZEN- |
GB0229803D0 (en) | 2002-12-20 | 2003-01-29 | Syngenta Ltd | Chemical process |
ITMI20031333A1 (en) | 2003-06-30 | 2005-01-01 | Erregierre Spa | PREPARATION PROCESS OF CHLOHRIDATE RALOXIFENE. |
US7435849B2 (en) | 2005-10-31 | 2008-10-14 | Hoffmann-La Roche Inc. | Process for the production of acid chlorides |
EP1935867A1 (en) * | 2006-12-20 | 2008-06-25 | F. Hoffmann-La Roche Ag | Process for preparing 1-(2-ethyl-butyl)-cyclohexanecarboxylic acid |
EP2274264B1 (en) * | 2008-04-04 | 2014-02-12 | F. Hoffmann-La Roche AG | New process for the preparation of cyclohexanecarboxylic acid derivatives via the corresponding cyclohexanecarboxamide derivative |
-
2009
- 2009-03-26 ES ES09728035.8T patent/ES2592727T3/en active Active
- 2009-03-26 AU AU2009231423A patent/AU2009231423B2/en active Active
- 2009-03-26 CA CA2717955A patent/CA2717955C/en active Active
- 2009-03-26 BR BRPI0909813-5A patent/BRPI0909813B1/en active IP Right Grant
- 2009-03-26 WO PCT/EP2009/053581 patent/WO2009121788A1/en active Application Filing
- 2009-03-26 MX MX2010009926A patent/MX2010009926A/en active IP Right Grant
- 2009-03-26 EP EP09728035.8A patent/EP2274278B1/en active Active
- 2009-03-26 KR KR1020107021983A patent/KR101279751B1/en active IP Right Grant
- 2009-03-26 CN CN200980111292.3A patent/CN101981001B/en active Active
- 2009-03-26 JP JP2011502347A patent/JP5564487B2/en active Active
- 2009-03-31 US US12/414,698 patent/US8143442B2/en active Active
-
2010
- 2010-08-05 IL IL207431A patent/IL207431A/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4283420A (en) * | 1978-04-27 | 1981-08-11 | Labaz | Pharmaceutically active cyclohexyl compounds and their preparation |
EP0094633A2 (en) * | 1982-05-17 | 1983-11-23 | Hoechst Aktiengesellschaft | Spiro-2-aza-alkane-3-carbonitriles, process for their preparation and their use |
EP1020439A1 (en) * | 1997-02-12 | 2000-07-19 | Japan Tobacco Inc. | Cetp activity inhibitors |
Non-Patent Citations (2)
Title |
---|
FAUVARSUE, J.-F. ET AL: "Propriétés des organomagnésiens dans l'hexyméthylphosphorotriamide (HMPT). Céténimination et alcoylation des nitriles.", COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L'ACADEMIE DES SCIENCES, SERIE C: SCIENCES CHIMIQUES, vol. 278, 1968, pages 1162 - 1165, XP002494707 * |
FLEMING, FRASER F. ET AL: "Metalated nitriles: Organolithium, -magnesium, and -copper exchange of .alpha.-halo nitriles", JOURNAL OF ORGANIC CHEMISTRY , 70(6), 2200-2205 CODEN: JOCEAH; ISSN: 0022-3263, 2005, XP002494612 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012035017A1 (en) | 2010-09-16 | 2012-03-22 | F. Hoffmann-La Roche Ag | New process |
CN103097345A (en) * | 2010-09-16 | 2013-05-08 | 霍夫曼-拉罗奇有限公司 | New process |
US20140336403A1 (en) * | 2010-09-16 | 2014-11-13 | Hoffmann-La Roche Inc. | Process |
US20160200672A1 (en) * | 2010-09-16 | 2016-07-14 | Hoffmann-La Roche Inc. | New process |
JP2014510019A (en) * | 2010-12-16 | 2014-04-24 | エフ.ホフマン−ラ ロシュ アーゲー | Process for the preparation of aromatic thiol derivatives by hydrogenation of disulfides. |
US9603816B2 (en) | 2010-12-16 | 2017-03-28 | Hoffmann-La Roche Inc. | Process |
WO2013007712A1 (en) | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Method for the preparation of cyclohexanecarboxylic acid |
US8975438B2 (en) | 2011-07-13 | 2015-03-10 | Hoffmann-La Roche Inc. | Process for the preparation of cyclohexanecarboxylic acid derivatives |
Also Published As
Publication number | Publication date |
---|---|
JP2011516447A (en) | 2011-05-26 |
AU2009231423B2 (en) | 2014-01-30 |
MX2010009926A (en) | 2010-09-28 |
US8143442B2 (en) | 2012-03-27 |
CN101981001B (en) | 2016-06-08 |
KR20100120311A (en) | 2010-11-15 |
IL207431A (en) | 2014-11-30 |
ES2592727T3 (en) | 2016-12-01 |
IL207431A0 (en) | 2010-12-30 |
AU2009231423A1 (en) | 2009-10-08 |
CA2717955A1 (en) | 2009-10-08 |
BRPI0909813A2 (en) | 2015-10-06 |
JP5564487B2 (en) | 2014-07-30 |
EP2274278A1 (en) | 2011-01-19 |
BRPI0909813B1 (en) | 2018-01-02 |
CA2717955C (en) | 2016-08-09 |
EP2274278B1 (en) | 2016-08-17 |
KR101279751B1 (en) | 2013-07-04 |
CN101981001A (en) | 2011-02-23 |
US20090253928A1 (en) | 2009-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2672505C (en) | Process for preparing 1-(2-ethyl-butyl)-cyclohexanecarboxylic acid | |
WO2009121788A1 (en) | New process for the preparatiion of cyclohexanecarboxylic acid dericatives | |
CA2717959C (en) | New process for the preparation of cyclohexanecarboxylic acid derivatives via the corresponding cyclohexanecarboxamide derivative | |
JP5325980B2 (en) | 1- (2-Ethyl-butyl) -cyclohexanecarboxylic acid ester as an intermediate in the preparation of pharmaceutically active amides | |
EP2616433B1 (en) | Process for preparing a cyclohexanecarbonitrile derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980111292.3 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09728035 Country of ref document: EP Kind code of ref document: A1 |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
REEP | Request for entry into the european phase |
Ref document number: 2009728035 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009728035 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 207431 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009231423 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2009231423 Country of ref document: AU Date of ref document: 20090326 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2717955 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2010/009926 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 20107021983 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011502347 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 6295/CHENP/2010 Country of ref document: IN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: PI0909813 Country of ref document: BR Kind code of ref document: A2 Effective date: 20100930 |